#United States #New Orleans #Ochsner Health #obesity management #Crux

A Game-Changing Partnership in Obesity Management

In an innovative move to address obesity management, Ochsner Connected Health has unveiled a partnership with Crux, marking a significant step forward in making cardiometabolic disease care more accessible and affordable for employers nationwide. This collaboration aims to revolutionize the way obesity is managed in the workplace, offering comprehensive support to employees in a challenging healthcare landscape.

The partnership introduces a robust employee benefits platform, where Crux takes the lead in negotiating with pharmaceutical companies to secure lower medication costs. This unique approach allows employers to offer GLP-1 medications—vital for managing obesity—at a price point that is both transparent and advantageous, without the burdens of rebates or complex reimbursement procedures typically associated with Pharmacy Benefit Managers (PBMs).

Transformative Solutions for Employers

Ochsner Connected Health and Crux are set to provide employers with a powerful array of benefits that focus on not just treatment, but on fostering long-term health outcomes. By integrating comprehensive cardiometabolic care and weight management via FDA-approved GLP-1 medications, employees are equipped with the resources they need to make substantial progress in their health journey.

The Ochsner Digital Medicine program offers evidence-based, clinically guided care for conditions such as obesity, Type 2 diabetes, and hypertension. This service empowers members by combining medical treatment with personalized lifestyle and behavioral support. The goal is to ensure that the care process is seamless, allowing members to work with their healthcare providers effectively, without disruption.

Key Benefits of the Partnership

• - Comprehensive Care: Employees gain access to evidence-based weight management and cardiometabolic support.
• - Seamless Implementation: The partnership ensures that existing provider relationships remain intact, avoiding disruptions in care delivery.
• - Affordable Access to GLP-1 Medications: With straightforward pricing and no hidden costs, employees can access the treatments they need without financial strain.

According to Dan Shields, CEO of Ochsner Digital Medicine, the current challenges employers face in balancing clinical impacts with costs are significant. He remarked, "Employers are struggling to balance the potentially vast clinical impact of GLP-1 medications with the cost to provide them. By combining clinical excellence with affordability, we're delivering a solution that improves health outcomes and reduces costs for businesses nationwide."

Ochsner's Commitment to Health Innovation

Ochsner Connected Health, a branch of the esteemed not-for-profit Ochsner Health system, has long been at the forefront of digital health advancements. With a focus on scalable digital health solutions, Ochsner's reputation is built on delivering high-quality, evidence-based care tailored to individual patient needs. Through its innovative Ochsner Digital Medicine program, the organization provides care across all 50 states, ensuring that members can effectively manage their health from any location.

This partnership between Ochsner and Crux not only addresses the physiological aspects of appetite and metabolism but also promises a more engaged and healthier workforce. By prioritizing accessible and comprehensive care, employers can see improved workplace health and employee engagement, leading to a more productive and satisfied workforce.

As the demand for effective obesity management continues to rise, the collaboration between Ochsner Connected Health and Crux positions itself as a beacon of hope for employers looking to provide their teams with the best possible healthcare resources. With this partnership, the focus remains clear: enhancing the health and well-being of employees while delivering results that align with business goals.